Showing results 1 to 20 of 52
next >
| Issue Date | Title | Author(s) |
| Jun-2022 | An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir | Liu, Yi-Qi; Zhang, Chi; Li, Jia-Wen; Cao, Li-Hua; Zhang, Zhan-Qing; Zhao, Wei-Feng; Shang, Qing-Hua; Zhang, Da-Zhi; Ma, An-Lin; Xie, Qing; Gui, Hong-Lian; Zhang, Guo; Liu, Ying-Xia; Shang, Jia; Xie, Shi-Bin; Li, Jun; Zhang, Xu-Qing; Zou, Zhi-Qiang; Chen, Yu-Ping; Zhang, Zong; Zhang, Ming-Xiang; Cheng, Jun; Zhang, Fu-Chun; Huang, Li-Hua; Li, Jia-Bin; Meng, Qing-Hua; Yu, Hai-Bin; Mi, Yu-Qiang; Peng, Yan-Zhong; Wang, Zhi-Jin; Chen, Li-Ming; Meng, Fan-Ping; Ren, Wan-Hua; Bai, Lang; Zeng, Yi-Lan; Fan, Rong; Lou, Xian-Zhi; Liang, Wei-Feng; Liu, Hui; Zhuang, Hui; Zhao, Hong; Wang, Gui-Qiang |
| 2018 | Baseline and Treatment Profiles of Patients Recruited in China Registry of Hepatitis B | Shan, Shan; You, Hong; Niu, Junqi; Shang, Jia; Zhang, Yuexin; Ren, Hong; Tang, Hong; Ding, Huiguo; Zhang, Lingyi; Nan, Yuemin; Han, Tao; Wang, Xiaozhong; Liu, Xiaoqing; Dou, Xiaoguang; Xu, Xiaoyuan; Wei, Lai; Hou, Jinlin; Duan, Zhongping; Zhuang, Hui; Kong, Yuanyuan; Jia, Jidong |
| 2018 | Baseline and Treatment Profiles of Patients Recruited in China Registry of Hepatitis B | Shan, Shan; You, Hong; Niu, Junqi; Shang, Jia; Zhang, Yuexin; Ren, Hong; Tang, Hong; Ding, Huiguo; Zhang, Lingyi; Nan, Yuemin; Han, Tao; Wang, Xiaozhong; Liu, Xiaoqing; Dou, Xiaoguang; Xu, Xiaoyuan; Wei, Lai; Hou, Jinlin; Duan, Zhongping; Zhuang, Hui; Kong, Yuanyuan; Jia, Jidong |
| Mar-2020 | China Registry of Hepatitis B (CR-HepB): Protocol and implementation of a nationwide hospital-based registry of hepatitis B | Shan, Shan; Wei, Wei; Kong, Yuanyuan; Niu, Junqi; Shang, Jia; Xie, Wen; Zhang, Yuexin; Ren, Hong; Tang, Hong; Ding, Huiguo; Nan, Yuemin; Dou, Xiaoguang; Han, Tao; Xu, Xiaoyuan; Duan, Zhongping; Wei, Lai; Hou, Jinlin; Zhuang, Hui; You, Hong; Jia, Jidong |
| 2019 | Chinese guidelines on management of hepatic encephalopathy in cirrhosis | Xu, Xiao-Yuan; Ding, Hui-Guo; Li, Wen-Gang; Jia, Ji-Dong; Wei, Lai; Duan, Zhong-Ping; Liu, Yu-Lan; Ling-Hu, En-Qiang; Zhuang, Hui; An, Ji-Hong; Cai, Da-Chuan; Chen, Guo-Feng; Chen, Hong-Song; Chen, Jing-Long; Chen, Yu; Cheng, Jun; Dou, Xiao-Guang; Feng, Zhi-Jie; Gao, Hui; Gao, Yan-Hang; Geng, Jia-Wei; Guo, Hui-Min; Guo, Wu-Hua; Han, Tao; Han, Ying; Huang, Yuan; Jiang, Jian-Ning; Jiang, Ying-An; Kong, Yuan-Yuan; Li, Cang-You; Li, Guang-Ming; Li, Jie; Li, Shu-Chen; Li, Tai-Sheng; Li, Yu-Fang; Liu, Jing-Feng; Liu, Xiao-Qing; Liu, Ying-Di; Lu, Lun-Gen; Luo, Xin-Hua; Ma, An-Lin; Ma, Xiong; Mao, Qing; Mao, Yi-Min; Nan, Yue-Min; Nie, Yu-Qiang; Ren, Hong; Ren, Wan-Hua; Shang, Jia; Wang, Lei; Wang, Yu-Ming; Wang, Xiao-Jun; Wu, Jing; Xie, Wei-Fen; Xie, Wen; Xin, Shao-Jie; Xing, Hui-Chun; Xu, Jian-Ming; Xu, Jie; Xu, Jing-Hang; Xu, You-Qing; Yan, Ming; Yang, Dong-Liang; Yang, Ji-Ming; Yang, Jin-Hui; Yang, Yong-Feng; Yang, Yong-Ping; You, Hong; Yu, Yan-Yan; Zhai, Suo-Di; Zhang, Chun-Qing; Zhang, Da-Zhi; Zhang, Ling-Yi; Zhang, Lun-Li; Zhang, Wen-Hong; Zhao, Jing-Min; Zhao, Ping; Zhao, Shou-Song; Zhu, Xuan; Zuo, Wei-Ze; Kang, Qian; Luo, Hao; Tan, Ning |
| Jun-2023 | Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation | Zhang, Sihui; Wang, Chao; Liu, Bei; Lu, Qing-Bin; Shang, Jia; Zhou, Yihua; Jia, Jidong; Xu, Xiaoyuan; Rao, Huiying; Han, Bingfeng; Zhao, Tianshuo; Chen, Linyi; Xie, Mingzhu; Cui, Jiahao; Du, Juan; Zeng, Jing; Huang, Ninghua; Liu, Yaqiong; Zhang, Lei; Zhuang, Hui; Cui, Fuqiang |
| Jun-2023 | Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation | Zhang, Sihui; Wang, Chao; Liu, Bei; Lu, Qing-Bin; Shang, Jia; Zhou, Yihua; Jia, Jidong; Xu, Xiaoyuan; Rao, Huiying; Han, Bingfeng; Zhao, Tianshuo; Chen, Linyi; Xie, Mingzhu; Cui, Jiahao; Du, Juan; Zeng, Jing; Huang, Ninghua; Liu, Yaqiong; Zhang, Lei; Zhuang, Hui; Cui, Fuqiang |
| 2014 | Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection | Rao, Huiying; Wei, Lai; Carlos Lopez-Talavera, Juan; Shang, Jia; Chen, Hong; Li, Jun; Xie, Qing; Gao, Zhiliang; Wang, Lei; Wei, Jia; Jiang, Jianning; Sun, Yongtao; Yang, Ruifeng; Li, Hong; Zhang, Haiying; Gong, Zuojiong; Zhang, Lunli; Zhao, Longfeng; Dou, Xiaoguang; Niu, Junqi; You, Hong; Chen, Zhi; Ning, Qin; Gong, Guozhong; Wu, Shuhuan; Ji, Wei; Mao, Qing; Tang, Hong; Li, Shuchen; Wei, Shaofeng; Sun, Jian; Jiang, Jiaji; Lu, Lungen; Jia, Jidong; Zhuang, Hui |
| 2019 | Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C | Wei, Lai; Shang, Jia; Ma, Yuanji; Xu, Xiaoyuan; Huang, Yan; Guan, Yujuan; Duan, Zhongping; Zhang, Wenhong; Gao, Zhiliang; Zhang, Mingxiang; Li, Jun; Jia, Jidong; Yang, Yongfeng; Wen, Xiaofeng; Wang, Maorong; Jia, Zhansheng; Ning, Bo; Chen, Yongping; Qi, Yue; Du, Jie; Jiang, Jianning; Tong, Lixin; Xie, Yao; Wu, Jinzi J. |
| 2015 | Efficacy and Safety of Peginterferon alfa-2b (40kD, Y Shape) (Pegberon) in HBeAg-positive CHB Patients - A Phase III, Randomized, Multi-center, Positive-Controlled, Open-label Clinical Study | Wang, Gui-Qiang; Hou, Feng-Qin; Lu, Wei; Shang, Jia; Gong, Guo-Zhong; Pan, Chen; Zhang, Ming-Xiang; Yin, Chi-Biao; Xie, Qing; Peng, Yan-Zhong; Chen, Shi-Jun |
| 2015 | Efficacy and Safety of Peginterferon alfa-2b (40kD, Y Shape) (Pegberon) in HBeAg-positive CHB Patients - A Phase III, Randomized, Multi-center, Positive-Controlled, Open-label Clinical Study | Wang, Gui-Qiang; Hou, Feng-Qin; Lu, Wei; Shang, Jia; Gong, Guo-Zhong; Pan, Chen; Zhang, Ming-Xiang; Yin, Chi-Biao; Xie, Qing; Peng, Yan-Zhong; Chen, Shi-Jun |
| Oct-2020 | Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks | Wang, Xiaomei; Wang, Zhongfeng; Chi, Xiumei; Wu, Ruihong; Jin, Qinglong; Xu, Hongqin; Gao, Xiuzhu; Yu, Lei; Chen, Yuping; Shang, Jia; Liu, Longgen; Zhang, Shuqin; Jiang, Yongfang; Zhang, Mingxiang; Tong, Qiaoxia; Zhang, Lunli; Tan, Youwen; Ma, Anlin; Dang, Shuangsuo; Xu, Bin; Jin, Zhenjing; Li, Jia; Li, Xiaobo; Lu, Fengmin; Niu, Junqi |
| 2018 | The experience of discrimination of individuals living with chronic hepatitis B in four provinces of China | Han, Bingfeng; Yuan, Qianli; Shi, Yuhui; Wei, Lai; Hou, Jinlin; Shang, Jia; Hans, Ying; Jin, Cunduo; Chan, Po-Lin; Zhuang, Hui; Li, Jie; Cui, Fuqiang |
| 2016 | Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B | You, Hong; Kong, Yuanyuan; Hou, Jinlin; Wei, Lai; Zhang, Yuexin; Niu, Junqi; Han, Tao; Ou, Xiaojuan; Dou, Xiaoguang; Shang, Jia; Tang, Hong; Xie, Qing; Ding, Huiguo; Ren, Hong; Xu, Xiaoyuan; Xie, Wen; Liu, Xiaoqing; Xu, Youqing; Li, Yujie; Li, Jie; Chow, Shein-Chung; Zhuang, Hui; Jia, Jidong |
| Oct-2021 | FUNCTIONAL CURE BASED ON PEGYLATED INTERFERON alpha IN LONG-TERM NUCLEOSIDE ANALOG SUPPRESSED HBEAG NEGATIVE CHRONIC HEPATITIS B: A MULTICENTER REAL-WORLD STUDY (EVEREST PROJECT IN CHINA), A SEQUENTIAL REPORT - THE PREDICTORS FOR HBsAg LOSS | Wu, Zeqian; Xie, Dongying; Fu, Lei; Zhang, Wenhua; Wei, Jia; Shang, Jia; Li, Guojun; Guo, Ying; Yang, Jiahong; Guan, Yujuan; Li, Jiabin; Chang, Jiabao; Huang, Guangyu; Peng, Yanzhong; Lin, Minghua; Zeng, Yilan; Li, Jia; Jiang, Jiaji; Jiang, Yongfang; Gu, Ye; Geng, Jiawei; Gao, Zhiliang |
| Jul-2021 | Functional cure based on pegylated interferon alpha in long-term nucleoside analog suppressed HBeAg negative chronic hepatitis B: A multicenter real-world study (everest project in china), a sequential report the predictors for HBsAg loss | Wu, Ze-Qian; Xie, Dong-Ying; Fu, Lei; Zhang, Wenhua; Wei, Jia; Shang, Jia; Li, Guojun; Guo, Ying; Yang, Jiahong; Guan, Yujuan; Li, Jiabin; Chang, Jiabao; Huang, Guangyu; Peng, Yanzhong; Lin, MInghua; Zeng Yilan; Li, Jia; Jiang, Jiaji; Jiang, Yongfang; Gu, Ye; Geng, Jiawei; Gao, Zhi-liang |
| Jul-2022 | Functional cure based on pegylated interferon alpha therapy in nucleoside analog-suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest Project in China)-3.5 years data update | Xie, Chan; Xie, Dongying; Fu, Lei; Zhang, Wen-hua; Wei, Jia; Li, Guojun; Yang, Jiahong; Chen, Xinyue; Li, Jia-bin; Shang, Jia; Guan, Yu-juan; Jiang, Yongfang; Guo, Ying; Zeng, Yi-lan; Chang, Jiabao; Peng, Yanzhong; Lin, Minghua; Huang, Guangyu; Li, Jia; Gu, Shengwang; Geng, Jia-wei; Gao, Zhiliang |
| 2019 | HEALTH RELATED QUALITY OF LIFE (HRQoL) IN COMPENSATED HBV-INDUCED LIVER CIRRHOSIS PATIENTS SIGNIFICANTLY IMPROVED AFTER ANTIVIRAL THERAPY | Hong, Jia; Wu, Xiaoning; Zhou, Jialing; Meng, Tongtong; Guan, Qiushuang; Piao, Hongxin; Feng, Bo; Jiang, Wei; Lu, Lungen; Chen, Yongpeng; Xie, Wen; Xu, Youqing; Huo, Lijuan; Zhang, Xuqing; Shang, Jia; Ma, Anlin; Cheng, Jilin; Han, Tao; Zou, Zhiqiang; Duan, Weijia; Wu, Shanshan; Kong, Yuanyuan; Ou, Xiaojuan; Jia, Jidong; You, Hong |
| 2014 | Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection | Feng, Bo; Yang, Rui-Feng; Xie, Qing; Shang, Jia; Kong, Fan-Yun; Zhang, Hai-Ying; Rao, Hui-Ying; Jin, Qian; Cong, Xu; Liu, Yun-Ye; Kang, Yi; Wei, Lai |
| 2019 | Incidence and Etiology of Drug-Induced Liver Injury in Mainland China | Shen, Tao; Liu, Yingxia; Shang, Jia; Xie, Qing; Li, Jun; Yan, Ming; Xu, Jianming; Niu, Junqi; Liu, Jiajun; Watkins, Paul B.; Aithal, Guruprasad P.; Andrade, Raul J.; Dou, Xiaoguang; Yao, Lvfeng; Lv, Fangfang; Wang, Qi; Li, Yongguo; Zhou, Xinmin; Zhang, Yuexin; Zong, Peilan; Wan, Bin; Zou, Zhengsheng; Yang, Dongliang; Nie, Yuqiang; Li, Dongliang; Wang, Yuya; Han, Xi'an; Zhuang, Hui; Mao, Yimin; Chen, Chengwei |
